DNA in situ hybridization as an adjunct in tumor diagnosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10396297.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
DNA in situ hybridization (ISH) methods, particularly fluorescence in situ hybridization, have gained broad acceptance in the clinical cytogenetic and research communities, but are used less frequently by noncytogenetic diagnostic pathology services. This review discusses tumor-related ISH, including the advantages and limitations of enzymatic detection ("insituhistochemistry"). The ISH applications are categorized with respect to diagnostic capabilities, ease of use, and cost.
Medical subject headings
- DNA, Neoplasm
- In Situ Hybridization, Fluorescence
- Neoplasms